Cytek Biosciences has opened a new innovation centre in Bellevue, Washington, relocating its previous Seattle-area operations to a dedicated R&D facility. The renovated site includes R&D laboratories, instrument service training, customer demonstrations, and assembly and testing operations. CEO Wenbin Jiang said the centre strengthens the company's ability to develop and deliver new technologies. Cytek stock closed Wednesday at $4.65, up 0.65%, and rose a further 3.01% in after-hours trading to $4.79.
Cytek Biosciences IncOpens new innovation centre with R&D labs, strengthening ability to develop new technologies.